Novo Nordisk Says It Will Slash the Price of Insulin

The New York Times - Business:

The company’s decision follows a similar move by its rival, Eli Lilly, this month.

Author: Rebecca Robbins

This post first appeared in The New York Times - Business. Read the original article.